Risk of nephrogenic systemic fibrosis in patients with impaired renal function undergoing fixed-dose gadoxetic acid-enhanced magnetic resonance imaging.
Ti-Yung TsengJeng-Hwei TsengBing-Shen HuangShen-Yen LinChun-Bing ChenYi-Wen FangGigin LinYing-Chieh LaiPublished in: Abdominal radiology (New York) (2021)
No NSF was detected in this study. However, it is premature to ascertain the risk of NSF using gadoxetic acid in patients with renal impairment and further studies are warranted.